• Cat-intel
  • MedIntelliX
  • Consulting
  • Resources
  • About Us
  • News
  • Careers
  • Contact Us
  • Login
    • Request Free Sample ×
    Infectious Disease Treatments Market Research Report – Forecast Till 2032 Infographic

    Kindly complete the form below to receive a free sample of this Report

    Leading companies partner with us for data-driven Insights

    clients tt-cursor

    Infectious Disease Treatments Market

    ID: MRFR/Pharma/1095-HCR
    90 Pages
    Kinjoll Dey
    September 2025

    Infectious Disease Treatments Market Research Report Information By Type (Viral Diseases, Bacterial Diseases) Treatment (Antibacterial, Antifungal Drugs, Antiviral Drugs) End Users (Hospitals & Clinics, Retail Pharmacies) - Forecast till 2032

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    Infectious Disease Treatments Market Research Report – Forecast Till 2032 Infographic
    Purchase Options
    $ 4,950.0
    $ 5,950.0
    $ 7,250.0
    Compare License
    Table of Contents

    Infectious Disease Treatments Market Summary

    As per Market Research Future Analysis, the Infectious Disease Treatments Market was valued at USD 58.02 Billion in 2023 and is projected to grow to USD 116.83 Billion by 2032, with a CAGR of 7.11% from 2024 to 2032. The market growth is driven by the increasing prevalence of infectious diseases such as tuberculosis (TB) and HIV/AIDS, alongside rising healthcare expenditures and patient awareness. However, challenges such as low treatment adoption and healthcare spending in developing economies may hinder growth. The market is segmented by type, treatment, and end users, with significant contributions from both viral and bacterial disease treatments. The Americas lead the market, followed by Europe and the Asia Pacific, which is the fastest-growing region.

    Key Market Trends & Highlights

    Key trends influencing the Infectious Disease Treatments Market include rising disease prevalence and advancements in treatment options.

    • Market Size in 2023: USD 58.02 Billion
    • Projected Market Size by 2032: USD 116.83 Billion
    • CAGR from 2024 to 2032: 7.11%
    • Major infectious diseases driving growth include TB and HIV/AIDS.

    Market Size & Forecast

    2023 Market Size USD 58.02 Billion
    2024 Market Size USD 62.94 Billion
    2032 Market Size USD 116.83 Billion

    Major Players

    Merck & Co., Inc. (U.S.), F. Hoffmann-La Roche Ltd (Switzerland), Pfizer Inc. (U.S.), GlaxoSmithKline plc. (U.K), AstraZeneca (U.K), Novartis AG (Switzerland), Sanofi (France), Mylan N.V. (U.S.)

    Infectious Disease Treatments Market Trends

    The ongoing evolution of infectious disease treatments reflects a dynamic interplay between emerging pathogens and advancements in medical technology, necessitating continuous adaptation in healthcare strategies.

    U.S. Department of Health and Human Services

    Infectious Disease Treatments Market Drivers

    Rising Incidence of Infectious Diseases

    The Global Infectious Disease Treatments Market Industry is experiencing a notable surge due to the increasing incidence of infectious diseases worldwide. Factors such as urbanization, climate change, and global travel contribute to the spread of pathogens, leading to higher demand for effective treatments. For instance, the World Health Organization reports that infectious diseases account for a significant portion of global morbidity and mortality. This growing burden is projected to drive the market value to approximately 62.9 USD Billion in 2024, highlighting the urgent need for innovative therapeutic solutions.

    Market Segment Insights

    Regional Insights

    Key Companies in the Infectious Disease Treatments Market market include

    Industry Developments

    Future Outlook

    Infectious Disease Treatments Market Future Outlook

    The Infectious Disease Treatments Market is projected to grow at a 7.78% CAGR from 2024 to 2035, driven by advancements in biotechnology, rising global health awareness, and increasing prevalence of infectious diseases.

    New opportunities lie in:

    • Invest in personalized medicine approaches to enhance treatment efficacy for specific infectious diseases.
    • Develop innovative delivery systems for vaccines to improve accessibility and patient compliance.
    • Leverage artificial intelligence for rapid drug discovery and development processes.

    By 2035, the market is expected to be robust, reflecting substantial advancements and increased investment in infectious disease treatments.

    Market Segmentation

    Infectious Disease Treatments Market Segmentation

    Key players for infectious disease treatments market
    • (U.S.)
    • F. Hoffmann-La Roche Ltd (Switzerland)
    • Pfizer Inc. (U.S.)
    • GlaxoSmithKline plc. (U.K)
    • (U.K)
    • Novartis AG (Switzerland)
    • Sanofi (France)
    • Mylan N.V. (U.S.)

    Report Scope

    Report Attribute/Metric Details
    Market Size 2023 58.02 (USD Billion)
    Market Size 2024 62.94 (USD Billion)
    Market Size 2032 116.83 (USD Billion)
    Compound Annual Growth Rate (CAGR) 7.11 % (2024 - 2032)
    Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
    Base Year 2023
    Market Forecast Period 2024 - 2032
    Historical Data 2019 - 2023
      Geographies Covered   North America, Europe, Asia-Pacific, and Rest of the World (RoW)
      Key Vendors   Merck & Co., Inc. (U.S.), F. Hoffmann-La Roche Ltd (Switzerland), Pfizer Inc. (U.S.), GlaxoSmithKline plc. (U.K), AstraZeneca (U.K), Novartis AG (Switzerland), Sanofi (France), Mylan N.V. (U.S.), and others
      Key Market Opportunities  Increasing healthcare expendituresGrowing awareness of the patients 
      Key Market Drivers   Increasing prevalence of the infectious diseases

    Market Highlights

    Author
    Kinjoll Dey
    Research Analyst Level I

    He is an extremely curious individual currently working in Healthcare and Medical Devices Domain. Kinjoll is comfortably versed in data centric research backed by healthcare educational background. He leverages extensive data mining and analytics tools such as Primary and Secondary Research, Statistical Analysis, Machine Learning, Data Modelling. His key role also involves Technical Sales Support, Client Interaction and Project management within the Healthcare team. Lastly, he showcases extensive affinity towards learning new skills and remain fascinated in implementing them.

    Get In Touch
    Leave a Comment

    FAQs

    What was the market size of the Infectious Disease Treatments Market in 2023?

    The Infectious Disease Treatments Market size was valued at USD 58.02 Billion in 2023.

    What is the projected market size of the Infectious Disease Treatments Market by 2032?

    The market is projected to grow to USD 116.83 Billion by 2032.

    What is the compound annual growth rate (CAGR) of the market during the forecast period (2024-2032)?

    The compound annual growth rate (CAGR) of the market is 7.11% during the forecast period.

    How is the market segmented on the basis of type?

    The market is segmented into viral diseases, bacterial diseases, and others. Viral diseases are further sub-segmented into AIDS, hepatitis B, hepatitis C, and others. Bacterial diseases are sub-segmented into tuberculosis (TB), bacterial meningitis, and others.

    Which region dominates the infectious disease treatments market and why?

    The Americas dominate the market due to a well-developed healthcare sector, a large patient population, increasing healthcare expenditure, changing lifestyles, and the presence of major players like Merck & Co., Inc., and Pfizer Inc.

    1. 'TABLE OF CONTENT
    2. Chapter 1.
    3. Report Prologue
    4. Chapter
    5. Market Introduction
      1. Definition
      2. Scope of the Study
        1. Research Objective
        2. Assumptions
        3. Limitations
    6. Chapter 3. Research Methodology
      1. Introduction
      2. Primary Research
      3. Secondary research
      4. Market
    7. Size Estimation
    8. Chapter
    9. Market Dynamics
    10. Drivers
    11. Restrains
    12. Opportunities
    13. Challenges
    14. Macroeconomic Indicators
      1. Treatment Trends & Assessment
    15. Chapter 5. Market Factor Analysis
      1. Porters Five Forces Analysis
        1. Bargaining Power
    16. of Suppliers
    17. Bargaining Power of Buyers
      1. Threat of New Entrants
        1. Threat of Substitutes
        2. Intensity of Rivalry
      2. Value Chain Analysis
      3. Investment Feasibility Analysis
      4. Pricing Analysis
    18. Chapter 6. Global Infectious
    19. Disease Treatments, by Type
      1. Introduction
      2. Viral Diseases Market Estimates & Forecast, 2020-2027
        1. Acquired Immunodeficiency
    20. Syndrome (AIDS)
    21. Hepatitis B
    22. Hepatitis C
    23. Others
    24. Bacterial Diseases Market Estimates & Forecast, 2020-2027
      1. Tuberculosis (TB)
        1. Bacterial meningitis
        2. Others
      2. Others
    25. Chapter 7. Global Infectious
    26. Disease Treatments, by Treatment
      1. Introduction
      2. Antibacterial Drugs Market Estimates & Forecast, 2020-2027
        1. Beta-Lactams
        2. Quinolones
        3. Sulfonamides
        4. Tetracyclines
        5. Others
      3. Antifungal Drugs
    27. Market Estimates & Forecast, 2020-2027
      1. Azoles
        1. Pyrimidines
        2. Echinodians
        3. Polyenes
        4. Others
      2. Antiviral Drugs Market Estimates & Forecast,
    28. Anti-parasitic Drugs Market Estimates & Forecast, 2020-2027
      1. Others
    29. Chapter 8. Global Infectious
    30. Disease Treatments, by End Users
      1. Introduction
      2. Hospitals & Clinics Market Estimates & Forecast, 2020-2027
      3. Research Organization
    31. Market Estimates & Forecast, 2020-2027
      1. Retail Pharmacies Market Estimates & Forecast,
    32. Others
    33. Chapter
    34. Global Infectious Disease Treatments, by Region
      1. Introduction
      2. America
        1. North America
        2. South America
      3. Europe
        1. Western Europe
        2. Eastern Europe
      4. Asia Pacific
        1. Japan
        2. China
        3. India
        4. Australia
        5. Republic of Korea
        6. Rest of Asia Pacific
      5. The Middle East &
    35. Africa
    36. United Arab Emirates
    37. Saudi Arabia
    38. Oman
    39. Kuwait
    40. Qatar
    41. Rest of the Middle East & Africa
    42. Chapter 10. Company Landscape
      1. Introduction
      2. Market Share Analysis
      3. Key Development & Strategies
        1. Key Developments
    43. Chapter 11
    44. Company Profiles
    45. Merck & Co., Inc.
    46. Company Overview
    47. Type Overview
    48. Financials
    49. Key Developments
    50. SWOT Analysis
    51. F. Hoffmann-La Roche Ltd
      1. Company Overview
        1. Type Overview
        2. Financial Overview
        3. Key Developments
        4. SWOT Analysis
      2. Pfizer Inc.
        1. Company Overview
        2. Type Overview
        3. Financial Overview
        4. Key Development
        5. SWOT Analysis
      3. GlaxoSmithKline plc.
        1. Company Overview
        2. Type/Business Segment Overview
        3. Financial Overview
        4. Key
    52. Development
    53. SWOT Analysis
    54. AstraZeneca
    55. Company Overview
    56. Type Overview
    57. Financial overview
    58. Key Developments
    59. SWOT Analysis
    60. Novartis AG
    61. Company Overview
    62. Type Overview
    63. Financial Overview
    64. Key Developments
    65. SWOT Analysis
    66. Sanofi
    67. Overview
    68. Type Overview
    69. Financials
    70. Key Developments
    71. SWOT Analysis
    72. Mylan N.V.
    73. Overview
    74. Type Overview
    75. Financials
    76. Key Developments
    77. SWOT Analysis
    78. Others
    79. Chapter
    80. MRFR Conclusion
    81. Key Findings
    82. From CEO’s View Point
      1. Unmet Needs of the Market
      2. Key Companies to Watch
      3. Prediction of Infectious Disease Treatments
    83. Market
    84. Chapter
    85. Appendix
    86. LIST
    87. OF TABLES
    88. Infectious Disease Treatments Industry Synopsis, 2020-2027
    89. and Forecast, 2020-2027, (USD Million)
    90. 2027, (USD Million)
    91. Million)
    92. Global Infectious Disease Treatments by Treatment, 2020-2027, (USD Million)
    93. Disease Treatments by End Users, 2020-2027, (USD Million)
    94. Market by Type, 2020-2027, (USD Million)
    95. by Treatment, 2020-2027, (USD Million)
    96. by End Users, 2020-2027, (USD Million)
    97. 2027, (USD Million)
    98. (USD Million)
    99. U.S. Infectious Disease Treatments Market by End Users, 2020-2027, (USD Million)
    100. Disease Treatments Market by Type, 2020-2027, (USD Million)
    101. by Treatment, 2020-2027, (USD Million)
    102. End Users, 2020-2027, (USD Million)
    103. by Type, 2020-2027, (USD Million)
    104. 2027, (USD Million)
    105. Users, 2020-2027, (USD Million)
    106. (USD Million)
    107. Europe Infectious Disease Treatments Market by Treatment, 2020-2027, (USD Million)
    108. Disease Treatments Market by End Users, 2020-2027, (USD Million)
    109. Disease Treatments Market by Type, 2020-2027, (USD Million)
    110. Market by Treatment, 2020-2027, (USD Million)
    111. Market by End Users, 2020-2027, (USD Million)
    112. Market by Type, 2020-2027, (USD Million)
    113. by Treatment, 2020-2027, (USD Million)
    114. by End Users, 2020-2027, (USD Million)
    115. by Type, 2020-2027, (USD Million)
    116. 2027, (USD Million)
    117. 2027, (USD Million)
    118. by Type, 2020-2027, (USD Million)
    119. by Treatment, 2020-2027, (USD Million)
    120. Market by End Users, 2020-2027, (USD Million)
    121. Treatments
    122. Market Dynamics for Global Infectious Disease Treatments
    123. by Type 2020
    124. Global Infectious Disease Treatments Share, by Treatment 2020
    125. Treatments Share, by End Users, 2020
    126. Region, 2020
    127. North America Infectious Disease Treatments Market Share, by Country, 2020
    128. Disease Treatments Market Share, by Country, 2020
    129. Market Share, by Country, 2020
    130. Share, by Country, 2020
    131. Merck & Co., Inc.: Key Financials
    132. Co., Inc.: Geographical Revenue
    133. Roche Ltd: Type UK Ltd: Segmental Revenue
    134. Geographical Revenue
    135. Pfizer Inc.: Key Financials
    136. plc.: Key Financials
    137. GlaxoSmithKline plc.: Segmental Revenue
    138. Key Financials
    139. AstraZeneca: Segmental Revenue
    140. Revenue
    141. Novartis AG: Geographical Revenue
    142. Revenue
    143. Mylan N.V.: Key Financials

    Infectious Disease Treatments Market Segmentation

    Market Segmentation Overview

    • Detailed segmentation data will be available in the full report
    • Comprehensive analysis by multiple parameters
    • Regional and country-level breakdowns
    • Market size forecasts by segment
    Infectious Disease Treatments Market Research Report – Forecast Till 2032 Infographic
    Free Sample Request

    Kindly complete the form below to receive a free sample of this Report

    Related Reports

    No regional reports available for this market.

    No country-specific reports available for this market.

    Customer Strories

    “I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

    Victoria Milne Founder
    Case Study

    Chemicals and Materials

    Global Magnesium Sulfate Market – Forecast till 2027